Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
USANA Health (DE:USJ)
FRANKFURT:USJ
Holding DE:USJ?
Track your performance easily
USJ Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€32.20 - €55.50
Previous Close€34.6
Volume0.00
Average Volume (3M)N/A
Market Cap
€659.03M
Enterprise Value€359.24M
Total Cash (Recent Filing)$332.42M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta0.28
Next Earnings
Oct 22, 2024EPS Estimate
€0.44Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding19,052,276
10 Day Avg. Volume0
30 Day Avg. VolumeN/A
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)1.32
Price to Sales (P/S)0.84
Price to Cash Flow (P/CF)23.00
P/FCF Ratio34.60
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.41
Enterprise Value/Gross Profit0.48
Enterprise Value/Ebitda2.00
Forecast
1Y Price Target
€34.01Price Target Upside-1.72% Downside
Rating ConsensusHold
Number of Analyst Covering1
USANA Health News
PremiumCompany Announcements
USANA Health Faces Q3 2024 Sales Decline Amid Challenges
USJ FAQ
What was USANA Health’s price range in the past 12 months?
USANA Health lowest stock price was €32.20 and its highest was €55.50 in the past 12 months.
What is USANA Health’s market cap?
Currently, no data Available
When is USANA Health’s upcoming earnings report date?
USANA Health’s upcoming earnings report date is Oct 22, 2024 which is 30 days ago.
How were USANA Health’s earnings last quarter?
USANA Health released its earnings results on Jul 23, 2024. The company reported €0.487 earnings per share for the quarter, missing the consensus estimate of €0.525 by -€0.038.
Is USANA Health overvalued?
According to Wall Street analysts USANA Health’s price is currently Overvalued.
Does USANA Health pay dividends?
USANA Health does not currently pay dividends.
What is USANA Health’s EPS estimate?
USANA Health’s EPS estimate is €0.44.
How many shares outstanding does USANA Health have?
USANA Health has 19,052,277 shares outstanding.
What happened to USANA Health’s price movement after its last earnings report?
USANA Health reported an EPS of €0.487 in its last earnings report, missing expectations of €0.525. Following the earnings report the stock price went down -3.349%.
Which hedge fund is a major shareholder of USANA Health?
Among the largest hedge funds holding USANA Health’s share is Pzena Investment Management LLC. It holds USANA Health’s shares valued at 44M.
---
USANA Health Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
€34.01 (-1.72% Downside)
€34.01 (-1.72% Downside)
Blogger Sentiment
Bullish
DE:USJ Sentiment 100%
Sector Average 71%
Sector Average 71%
Insider Transactions
Sold Shares
Worth $311.6K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-35.07%
12-Months-Change
Fundamentals
Return on Equity
11.23%
Trailing 12-Months
Asset Growth
4.77%
Trailing 12-Months
Company Description
USANA Health
USANA Health Sciences, Inc. develops and manufactures nutritional, personal care and weight-management products. Its product line divided into four categories: Essentials, Optimizers, Foods, and Sense-beautiful science. The Essentials Nutritionals category includes vitamin and mineral supplements that provide a foundation of advanced total body nutrition for every age group. The Optimizers Nutritionals category consists of targeted supplements that support cardiovascular health, skeletal and structural health, and digestive health. The Foods Nutritionals category includes low-glycemic meal replacement shakes, snack bars, and other related products that provide optimal macro-nutrition. The Sense-beautiful science includes premium, science-based, personal care products that support healthy skin and hair by providing topical nourishment, moisturization, and protection. The firm's brand include Procosa and MagneCal D. The company was founded by Myron W. Wentz in September 1992 and is headquartered in Salt Lake City, UT.
---
USJ Earnings Call
Q2 2024
0:00 / 0:00
---
USJ Stock 12 Month Forecast
Average Price Target
€34.01
▼(-1.72% Downside)
Technical Analysis
---